Free Trial

Alvotech (ALVOW) Competitors

$3.17
-0.38 (-10.70%)
(As of 05/31/2024 ET)

ALVOW vs. BFRIW, CLVRW, CYTHW, PROCW, SBFMW, ATNFW, SXTPW, ACONW, AIMDW, and DRTSW

Should you be buying Alvotech stock or one of its competitors? The main competitors of Alvotech include Biofrontera (BFRIW), Clever Leaves (CLVRW), Cyclo Therapeutics (CYTHW), Procaps Group (PROCW), Sunshine Biopharma (SBFMW), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), and Alpha Tau Medical (DRTSW). These companies are all part of the "medical" sector.

Alvotech vs.

Biofrontera (NASDAQ:BFRIW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

In the previous week, Biofrontera and Biofrontera both had 1 articles in the media. Alvotech's average media sentiment score of 1.89 equaled Biofrontera'saverage media sentiment score.

Company Overall Sentiment
Biofrontera Very Positive
Alvotech Very Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biofrontera
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Alvotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$33.25MN/AN/AN/AN/A
Alvotech$112.42MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Alvotech N/A N/A N/A

Biofrontera and Alvotech both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
BiofronteraN/AN/A
AlvotechN/AN/A

Summary

Alvotech beats Biofrontera on 1 of the 1 factors compared between the two stocks.

Get Alvotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALVOW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALVOW vs. The Competition

MetricAlvotechDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.19B$5.17B$7.99B
Dividend YieldN/A3.07%2.76%4.00%
P/E RatioN/A545.16105.5514.55
Price / SalesN/A9,249.212,386.0773.53
Price / CashN/A10.4335.4131.55
Price / BookN/A8.195.544.59
Net IncomeN/A$159.95M$106.07M$213.90M
7 Day Performance7.09%0.11%1.14%0.87%
1 Month Performance-16.80%-0.77%0.69%1.82%
1 Year Performance188.16%35.89%2.66%5.90%

Alvotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BFRIW
Biofrontera
0 of 5 stars
$0.06
+50.0%
N/AN/A$0.00$33.25M0.0083Positive News
Gap Up
CLVRW
Clever Leaves
0 of 5 stars
$0.01
flat
N/A-38.6%$0.00$17.42M0.00296Short Interest ↑
News Coverage
Positive News
Gap Up
CYTHW
Cyclo Therapeutics
0 of 5 stars
$0.25
flat
N/A-17.5%$0.00$1.13M0.008Positive News
PROCW
Procaps Group
0 of 5 stars
$0.04
flat
N/AN/A$0.00$414.10M0.005,500Short Interest ↑
SBFMW
Sunshine Biopharma
0 of 5 stars
$0.08
-27.3%
N/AN/A$0.00$26.74M0.0044Positive News
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-42.9%$0.00N/A0.004Positive News
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.08
flat
N/AN/A$0.00$352,864.000.002Positive News
ACONW
Aclarion
0 of 5 stars
$0.03
-24.9%
N/A-76.8%$0.00$60,048.000.004Gap Down
AIMDW
Ainos
0 of 5 stars
$0.05
-30.7%
N/AN/A$0.00$93,677.000.0046Positive News
Gap Down
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.23
-4.2%
N/A-35.1%$0.00N/A0.00121Short Interest ↑
News Coverage
Gap Up

Related Companies and Tools

This page (NASDAQ:ALVOW) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners